SNN Smith & Nephew Corp: צמיחת הכנסות רבעונית

לוגו תאגידי של חברת Smith & Nephew (SNN)

Logistics and inventory issues are weighing on profitability, which is reflected in the quarterly revenue growth rate; the value of 3.50 characterizes this level. Positive momentum is driven by the CORI robotic system and sports medicine. Meanwhile, Smith & Nephew plc (SNN) is developing nano-coatings and tissue regeneration, confirming its status as a technological leader in the production of orthopedic biomaterials.

SNN (Smith & Nephew PLC) היסטוריית צמיחת מכירות מרבעון לרבעון מ-04.07.2022 עד 20.11.2026

SNN (Smith & Nephew): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
- מדדי מזומנים ותזרימי מזומנים:
ניתוח כל מדדי החברה:SNN - Smith & Nephew plc
מוצרים מיוצרים של smith-nephew.com

Smith & Nephew plc (SNN) maintains a strong position in the medtech sector, competing through innovative implants. This indicator measures the percentage change in sales volume between consecutive quarters, allowing investors to assess real sales dynamics without market noise. By analyzing the current growth rate of quarterly revenue, one can track the effectiveness of logistics restructuring and the recovery of margins in the sports medicine segment. A steady acceleration of this metric confirms a successful operational turnaround of the business.